Archive Category: Green Zone Fortunes PRO Updates

Back in July, when I first dug into Danaos Corp. (DAC), it wasn’t the dividend that caught my eye. It was the Quality numbers. Gross margin. Net margin. Return on assets, on equity and on invested capital. Those are the numbers that tell you whether a business really makes money, or just moves a lot of it around.

Stand up too fast, and the room tilts for a second. You grab the counter. It passes. Now imagine it doesn’t pass. Imagine your blood pressure drops so hard every time you stand that your vision goes gray and your legs give out. That’s daily life for many people with multiple system atrophy, a rare and devastating disease of the nervous system.

Twenty-seven months ago, I sent you the first recommendation in the history of Green Zone Fortunes PRO. It was June 17, 2024. The stock was SIGA Technologies Inc. (SIGA). You paid $6.60 a share. I still remember writing that report. SIGA made one drug, TPOXX, the first drug the U.S. Food and Drug Administration (FDA) ever approved to treat smallpox.

Last Thursday at 12:55 p.m., an email came in from a reader who’d written to me before. Not to say nice things. His words, not mine. He had emailed us “a time or two” when he thought we’d mishandled a promotional event, and by his own admission was “pretty candid and harsh.”

On March 27, 2000, Cisco Systems (CSCO) closed at $80.06 a share. That day, it was the most valuable public company on Earth. Two days earlier, it had passed Microsoft (MSFT), reaching $579.2 billion compared with MSFT’s $578.2 billion. Everyone owned it. Pension funds owned it. Index funds owned it. Your neighbor owned it and told you about it over the fence.